Beijing and Shanghai – March 20, 2019 – Cooley took home awards in two categories as part of China Business Law Journal’s annual China Business Awards. The firm is one of only seven international law firms named to the private equity & venture capital and healthcare, pharma & life sciences categories.
“Cooley has been active in the Chinese market for more than three decades and our recent expansion to Beijing is the latest example of our strong velocity,” said Christina Zhang, partner in charge of Cooley’s Shanghai office, which opened in 2011. “We’re honored to be awarded for our work in this critical region alongside other elite international firms, especially as we work to further expand our global capabilities.”
To determine the winners, editors from China Business Law Journal evaluated law firms on their landmark deals, cases and other notable achievements in the past year, in addition to carefully considering recommendations and comments received from corporate counsel, senior managers and legal professionals from around the globe.
Cooley recently announced its plans to launch in Hong Kong, following on the success of the firm’s Shanghai and Beijing offices. The firm represents some of Asia’s most innovative and dynamic tech and life sciences companies, advising on their financing, joint venture and other strategic transactions. In addition, Cooley has helped more than 80 fund managers form 100+ Chinese venture capital and private equity funds. It was named Investment Funds International Firm of the Year at the China Law & Practice Awards and has been broadly recognized for its strong tech, life sciences and VC practices. Additionally, Cooley made its first appearances on Legal 500 Asia-Pacific and Chambers Asia-Pacific – the firm’s first year submitting to those outlets for the region.
About Cooley LLP
Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.
Cooley has 1,000+ lawyers across 14 offices in the United States, China and Europe.